PLXNA3 and polycystic ovary syndrome: The PCOS model constructed by subcutaneous injection of DHEA showed a disordered oestrus cycle, polycystic formation of ovarian atresia follicles, regression of granulosa cells, disturbed sex hormone levels, and metabolic dysfunction, including weight gain, increased leptin levels and insulin resistance.